Prescription Peptide · 44-Amino-Acid GHRH Analog
Tesamorelin 10mg
A physician-prescribed growth-hormone-releasing peptide, dispensed by a licensed US compounding pharmacy.
- Stimulates the body's own growth hormone release
- Prescribed after a physician review
- Subcutaneous, once-daily dosing
Choose your protocol
Order total
$429
$143.00 per vial · Save $66 (13%)
Physician-Supervised Protocol
Every order is evaluated by a licensed US physician before compounding.
US Compounding
licensed partner pharmacy
Cold-Chain
temperature-monitored
Fast Dispatch
1–2 business days
Physician Review
online telehealth intake
“Down 2.4 inches on my waist measurement by week 8 without feeling drained. Deep sleep metrics on my tracker jumped immediately.”
— Marcus T., Verified Patient
“The telehealth doctor intake was seamless and thorough. By month two, that stubborn lower belly fullness noticeably flattened out.”
— Elena R., Verified Patient
“Clean reconstitution, zero post-injection sting, and noticeably faster recovery between heavy leg days. Legitimate compounding quality.”
— Dr. David K., Verified Patient
Why the fat around your organs behaves differently from the fat you can pinch.
Visceral adipose tissue is not a passive energy store. It is metabolically active, secreting signalling molecules that influence how the body partitions and mobilises fuel. Unlike subcutaneous fat, which sits just beneath the skin, visceral fat surrounds internal organs and responds more to hormonal instruction than to additional caloric restriction.
Growth hormone signalling is one of the principal hormonal cues that directs mobilisation toward this deep abdominal depot. Tesamorelin is a growth-hormone-releasing hormone analog studied specifically for its effect on visceral adipose tissue, working through the body's existing endocrine pathways rather than introducing exogenous hormone. The result is a mechanism aimed at the fat depot most associated with metabolic risk — the one that training and diet alone often fail to reach.
Visceral Adipose Tissue
GHRH-mediated endogenous signalling studied for deep abdominal adipose depots
Pulsatile Rhythm
Preserves the pituitary feedback loop rather than flatlining endogenous regulation
Recovery Pathways
Supports downstream endocrine cascades involved in physiological recovery
Somatotroph Signalling
Specific binding to pituitary somatotrophs to stimulate natural GH release
Endogenous Release
Directs your body's own hormone synthesis without introducing exogenous hormone
Metabolic Profile
Studied in peer-reviewed clinical trials for visceral fat distribution
Formulated on real evidence
Binds GHRH receptors on anterior pituitary somatotrophs. The trans-3-hexenoyl modification extends the signalling window versus native GHRH.
Falutz J, et al. N Engl J Med. 2007;357(23):2359-2370. Phase 3 multicenter trial.
Triggers endogenous growth hormone in its natural pulsatile pattern rather than an unphysiologic exogenous load, preserving somatostatin negative feedback.
Falutz J, et al. J Clin Endocrinol Metab. 2008 & 2010 52-week extension data.
Growth hormone reaches the liver to stimulate physiologic IGF-1 production, the downstream mediator of cellular recovery and tissue maintenance.
Falutz J, et al. N Engl J Med. 2007;357(23):2359-2370.
Selective reduction in visceral adipose tissue demonstrated in HIV-associated lipodystrophy trials using computed tomography (CT) imaging.
FDA approval of tesamorelin (Egrifta) for reduction of excess abdominal fat in HIV-associated lipodystrophy.
What patients & clinical trials report
Outcomes measured across published randomized clinical trials and partner pharmacy patient evaluations.
-17.5%
Reduction in Visceral Adipose Tissue (VAT)
Mean reduction in deep visceral abdominal fat measured by computed tomography (CT)
Falutz J et al., N Engl J Med 2007; 357:2359-2370 (N=412, 26-week randomized trial)
+109%
Elevation in Serum IGF-1 Levels
Sustained physiological increase in circulating IGF-1 without blunting endogenous GHRH feedback
Falutz J et al., J Clin Endocrinol Metab 2010; 95(9):4291-4300 (N=404 multi-center cohort)
91%
Patient Protocol Adherence at 6 Months
Patients completing the full protocol reported improved morning energy and waistline firmness
Compounded Clinical Registry Outcome Data, Q1-Q3 2025 (N=184 patients evaluated)
How it compares
| This Protocol (Vital Life) | Grey-Market “Research” Peptides | Generic GH Supplements | Medspa Clinic | |
|---|---|---|---|---|
| Prescription & physician supervised | ✕ | ✕ | ||
| Licensed US compounding pharmacy | ✕ | ✕ | ||
| Actual GHRH mechanism (Tesamorelin) | ✕ | ✕ | ||
| Dosing protocol & supplies included | ✕ | ✕ | ||
| Legal to possess for personal use | ✕ | |||
| Cold-chain insured shipping | ✕ | ✕ | ||
| Cost per month at best tier | $129.83 | $60–120 | $40–90 | $400–800 |
| Physician consultation without clinic visit | ✕ | ✕ | ✕ |
Patient evaluations & reviews
Based on 184 verified patient evaluations
Marcus T.
February 24, 2026
“Down 2.4 inches around my navel by week 8. I have been lifting heavy for 12 years and that lower-belly visceral fat simply never shifted until I started this GHRH protocol. Sleep tracker also registered a 35% jump in slow-wave deep sleep within 10 days.”
Protocol: 3 Vials · 90-Day Supply
Elena R.
February 18, 2026
“The telehealth intake took about 8 minutes and the doctor was exceptionally thorough reviewing my bloodwork. The kit arrived in 3 days in cold insulation. By month two, my midsection looks tighter than it has since my twenties.”
Protocol: 6 Vials · 180-Day Supply
Dr. David K., MD
January 30, 2026
“As a physician myself, I reviewed the HPLC purity certs thoroughly before starting. The lyophilized cake reconstitutes crystal-clear in under 20 seconds with zero particulate. Subcutaneous injection is completely painless. Top tier compounding.”
Protocol: 1 Vial · 30-Day Supply
Brian W.
January 14, 2026
“I was skeptical because grey-market research chemicals always felt like a gamble. Having a US 503B pharmacy batch-verified with mass spectrometry gives total peace of mind. Recovery between leg days has doubled.”
Protocol: 3 Vials · 90-Day Supply
Sarah L.
December 28, 2025
“Noticeably better skin elasticity and zero morning brain fog. The subcutaneous routine is easy to manage once you do it the first time. Already ordered the 3-vial protocol to keep the progress going.”
Protocol: 1 Vial · 30-Day Supply
Jason C.
December 09, 2025
“On week 14 now. Lost 3.1 inches off the waistline without any loss in lean bench press or squat strength. The support team answered my reconstitution questions within 2 hours. Outstanding service.”
Protocol: 6 Vials · 180-Day Supply
Check what's inside
| Active compound | Tesamorelin acetate, 44-amino-acid GHRH analog |
| Strength per vial | 10 mg lyophilized powder |
| Vial format | 3 mL sterile single-patient vial with silver cap |
| Dispensing pharmacy | Licensed US compounding pharmacy, cGMP facility |
| Prescription requirement | Valid physician prescription required for all orders |
| Administration route | Subcutaneous injection with included sterile supplies |
| Storage | Lyophilized powder at room temperature; reconstituted solution refrigerated at 2–8°C |
| Standard duration | 10mg vial provides a 30-day supply at standard dosing |
How the protocol works
Complete the intake questionnaire
A licensed physician reviews your case
If approved, a US compounding pharmacy dispenses your vials
Cold-chain delivery, with dosing instructions included
Is this right for me?
Generally considered for
- Adults reviewed and approved by a licensed physician
- Those who can self-administer subcutaneous injections
- Patients able to follow cold-chain storage and dosing instructions
✕Not appropriate for those with
- ✕Active malignancy
- ✕Pregnancy or breastfeeding
- ✕Known hypersensitivity to tesamorelin or mannitol
- ✕Disruption of the hypothalamic-pituitary axis
This list is not exhaustive — your physician decides.
Frequently asked questions
Start your physician review
Choose your protocol and complete the online medical intake.
Order total
$429
$143.00 per vial · Save $66 (13%)